Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
RESEARCH TOOLSreports
Total Valuation
Bausch Health Companies has a market cap or net worth of $2.42B. The enterprise value is C$34.10B.
Market Cap$2.42B
Enterprise ValueC$34.10B
Share Statistics
Bausch Health Companies has 369,550,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding369,550,080
Owned by Insiders19.01%
Owned by Institutions0.08%
Financial Efficiency
Bausch Health Companies’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -2.97%.
Return on Equity (ROE)0.04
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-2.97%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee464.98K
Profits Per Employee-3.48K
Employee Count20,700
Asset Turnover0.36
Inventory Turnover1.74
Valuation Ratios
The current PE Ratio of Bausch Health Companies is -64.60. Bausch Health Companies’s PEG ratio is 0.70.
PE Ratio-64.60
PS Ratio0.00
PB Ratio-2.32
Price to Fair Value-2.32
Price to FCF2.36
Price to Operating Cash Flow1.86
PEG Ratio0.70
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 9.63B and earned -46.00M in profits. Earnings per share was -0.12.
Revenue9.63B
Gross Profit6.84B
Operating Income1.55B
Pretax Income167.00M
Net Income-46.00M
EBITDA2.82B
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was 1.60B and capital expenditures -381.00M, giving a free cash flow of 1.22B billion.
Operating Cash Flow1.60B
Free Cash Flow1.22B
Free Cash Flow per Share3.29
Dividends & Yields
Bausch Health Companies pays an annual dividend of C$1.38, resulting in a dividend yield of ―
Dividend Per ShareC$1.38
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change-31.02%
50-Day Moving Average8.58
200-Day Moving Average9.91
Relative Strength Index (RSI)35.72
Average Volume (3m)442.53K
Important Dates
Bausch Health Companies upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend DateNov 10, 2010
Financial Position
Bausch Health Companies as a current ratio of 0.86, with Debt / Equity ratio of -1818.26%
Current Ratio0.86
Quick Ratio0.62
Debt to Market Cap7.27
Net Debt to EBITDA7.24
Interest Coverage Ratio1.11
Taxes
In the past 12 months, Bausch Health Companies has paid 239.00M in taxes.
Income Tax239.00M
Effective Tax Rate1.43
Enterprise Valuation
Bausch Health Companies EV to EBITDA ratio is 8.29, with an EV/FCF ratio of 18.62.
EV to Sales2.43
EV to EBITDA8.29
EV to Free Cash Flow18.62
EV to Operating Cash Flow14.66
Balance Sheet
Bausch Health Companies has $1.13B in cash and marketable securities with ― in debt, giving a net cash position of $20.38B billion.
Cash & Marketable Securities$1.13B
Total Debt―
Net Cash$20.38B
Net Cash Per Share$55.14
Tangible Book Value Per Share-$46.09
Margins
Gross margin is 70.78%, with operating margin of 16.06%, and net profit margin of -0.48%.
Gross Margin70.78%
Operating Margin16.06%
Pretax Margin1.74%
Net Profit Margin-0.48%
EBITDA Margin29.32%
EBIT Margin16.16%
Analyst Forecast
The average price target for Bausch Health Companies is $10.34, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$10.34
Price Target Upside58.80% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast11.87%
EPS Growth Forecast91.09%